AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2023
Feb 15, 2023
29809_dirs_2023-02-14_f60f0d5d-5e47-427f-88e0-eb8a9736cdf0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2023-02-13
Reporting Person: MOHR MARSHALL (Executive VP Global Business S)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-13 | Common Stock | M | 54000 | $63.2456 | Acquired | 54000 | Direct |
| 2023-02-13 | Common Stock | S | 33249 | $245.6127 | Disposed | 20751 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-13 | Non-Qualified Stock Option (right to buy) | $63.2456 | M | 54000 | Disposed | 2023-02-15 | Common Stock (54000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 100353 | Indirect |
Footnotes
F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 8, 2023.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $245.10 to $246.47 as follows: 29,736 shares sold at $245.10 to $246.10; and 3,513 shares sold at $246.15 to $246.47. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 1/8 six months after the date of grant and 1/48th each month thereafter.